X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under terms of the partnerships, Orange Grove Bio will work with YUHS and POSTECH to advance the development and commercialization of novel therapeutics in the areas of oncology, as well as autoimmune and inflammatory diseases.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Undisclosed
Partner/Sponsor/Collaborator: Yonsei University Health System
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration March 23, 2023
Details:
Under the collaboration, Orange Grove Bio will provide commercialization guidance and support to Cincinnati Children’s Innovation Ventures. Orange Grove Bio’s chief will advise on potential of emerging technologies from the Cincinnati Children’s Innovation Ventures pipeline.
Lead Product(s): Undisclosed
Therapeutic Area: Immunology Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Undisclosed
Partner/Sponsor/Collaborator: Cincinnati Children’s Hospital Medical Center
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration March 09, 2022
Details:
Through the newly established program, Einstein scientists will have the opportunity to receive expert mentorship and financial support to advance their foundational research and streamline translation of their discoveries into new drug candidates.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Undisclosed
Partner/Sponsor/Collaborator: Albert Einstein College of Medicine
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership October 21, 2021
Details:
Proceeds from the financing will support the company’s continued advancement of its lead drug candidates toward first-in-human clinical studies, including submission of the company’s first investigational new drug (IND) application.
Lead Product(s): Undisclosed
Therapeutic Area: Immunology Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Viva BioInnovator
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Financing October 05, 2021
Details:
Proceeds from the financing will support the company’s continued advancement of its lead drug candidates toward first-in-human clinical studies, including submission of the company’s first investigational new drug (IND) application.
Lead Product(s): Undisclosed
Therapeutic Area: Immunology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Small molecule
Partner/Sponsor/Collaborator: Viva BioInnovator
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Financing October 05, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
